Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Clinical trial NCT01078662 · COMPLETED

Trial details

NCT number: NCT01078662
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Breast Prostate Pancreatic Advanced Tumours

Start date: 2010-02-21
Primary completion: 2012-07-31
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.